940 SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE HCV POLYMERASE INHIBITOR VCH-222 FOLLOWING SINGLE DOSE ADMINISTRATION IN HEALTHY VOLUNTEERS AND ANTIVIRAL ACTIVITY IN HCV-INFECTED INDIVIDUALS

2009 ◽  
Vol 50 ◽  
pp. S342 ◽  
Author(s):  
C. Cooper ◽  
R. Larouche ◽  
B. Bourgault ◽  
N. Chauret ◽  
L. Proulx
1992 ◽  
Vol 52 (4) ◽  
pp. 417-426 ◽  
Author(s):  
Franck Le Coz ◽  
Christian Funck-Brentano ◽  
Jean-Marie Poirier ◽  
Yves Kibleur ◽  
François Xavier Mazoit ◽  
...  

2004 ◽  
Vol 48 (12) ◽  
pp. 4650-4653 ◽  
Author(s):  
Rainer Gattringer ◽  
Eleonora Urbauer ◽  
Friederike Traunmüller ◽  
Markus Zeitlinger ◽  
Pejman Dehghanyar ◽  
...  

ABSTRACT By use of microdialysis we assessed the concentrations of telithromycin in muscle and adipose tissue to test its ability to penetrate soft tissues. The ratios of the area under the concentration-versus-time curve from 0 to 24 h to the MIC indicated that free concentrations of telithromycin in tissue and plasma might be effective against Streptococcus pyogenes but not against staphylococci and human and animal bite pathogens.


Sign in / Sign up

Export Citation Format

Share Document